Atlas Trials

SGLT2 Inhibitors and Metformin on Metabolism and Non-Alcoholic SteatoHepatitis

Clinical trial NCT02696941 · COMPLETED

Trial details

NCT number
NCT02696941
Sponsor
University of Oxford
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Non-alcoholic Fatty Liver Disease
Start date
2016-02-01
Primary completion
2018-04-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.